| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Esperion Therapeutics, Inc. | Director | Common Stock | 24.6K | $30.6K | $1.25 | May 27, 2021 | By Alta Bioequities, L.P. |
| Esperion Therapeutics, Inc. | Director | Common Stock | 23.4K | $29.2K | $1.25 | May 27, 2021 | Direct |
| Allakos Inc. | Director | Stock Option (Right to buy) | 86.8K | May 25, 2023 | Direct | ||
| Krystal Biotech, Inc. | Director | Stock Option (Right to Buy) | 5K | Jun 30, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| KRYS | Krystal Biotech, Inc. | Jun 30, 2024 | 1 | $0 | 4 | Jul 1, 2024 | Director |
| KRYS | Krystal Biotech, Inc. | Jun 30, 2023 | 1 | $0 | 4 | Jul 3, 2023 | Director |
| KRYS | Krystal Biotech, Inc. | Jun 8, 2023 | 9 | -$6.42M | 4 | Jun 9, 2023 | Director |
| ALLK | Allakos Inc. | May 25, 2023 | 1 | $0 | 4 | May 30, 2023 | Director |
| KRYS | Krystal Biotech, Inc. | May 19, 2023 | 1 | -$4.75M | 4 | May 23, 2023 | Director |
| KRYS | Krystal Biotech, Inc. | May 9, 2023 | 1 | -$1.55M | 4 | May 11, 2023 | Director |
| KRYS | Krystal Biotech, Inc. | Apr 19, 2023 | 1 | -$713K | 4 | Apr 21, 2023 | Director |
| ALLK | Allakos Inc. | Sep 21, 2022 | 1 | $2.38M | 4 | Sep 23, 2022 | Director, 10%+ Owner |
| KRYS | Krystal Biotech, Inc. | Jun 30, 2022 | 1 | $0 | 4 | Jul 1, 2022 | Director |
| ALLK | Allakos Inc. | May 25, 2022 | 1 | $0 | 4 | May 27, 2022 | Director |
| KRYS | Krystal Biotech, Inc. | Dec 30, 2021 | 1 | $0 | 5 | Feb 2, 2022 | Director |
| KRYS | Krystal Biotech, Inc. | Dec 10, 2021 | 1 | -$7.05M | 4 | Dec 14, 2021 | Director |
| KRYS | Krystal Biotech, Inc. | Jun 30, 2021 | 1 | $0 | 4 | Jul 2, 2021 | Director |
| ESPR | Esperion Therapeutics, Inc. | May 27, 2021 | 1 | $0 | 4 | May 28, 2021 | Director |
| ALLK | Allakos Inc. | May 25, 2021 | 1 | $0 | 4 | Oct 14, 2021 | Director |